Bio-Rad Laboratories Inc (BIO)
350.23
-12.97
(-3.57%)
USD |
NYSE |
Nov 14, 16:00
350.20
-0.03
(-0.01%)
Pre-Market: 05:47
Bio-Rad Laboratories Cash from Investing (Quarterly): -55.64M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -55.64M |
| June 30, 2024 | -30.93M |
| March 31, 2024 | -43.09M |
| December 31, 2023 | 72.20M |
| September 30, 2023 | -9.50M |
| June 30, 2023 | 27.98M |
| March 31, 2023 | -70.47M |
| December 31, 2022 | -58.55M |
| September 30, 2022 | -88.42M |
| June 30, 2022 | -144.48M |
| March 31, 2022 | -916.14M |
| December 31, 2021 | -567.43M |
| September 30, 2021 | -81.35M |
| June 30, 2021 | -100.28M |
| March 31, 2021 | -48.33M |
| December 31, 2020 | -59.75M |
| September 30, 2020 | 90.85M |
| June 30, 2020 | -88.57M |
| March 31, 2020 | -12.42M |
| December 31, 2019 | -61.20M |
| September 30, 2019 | -109.91M |
| June 30, 2019 | -15.07M |
| March 31, 2019 | -22.71M |
| December 31, 2018 | -54.81M |
| September 30, 2018 | -29.51M |
| Date | Value |
|---|---|
| June 30, 2018 | -83.84M |
| March 31, 2018 | -18.82M |
| December 31, 2017 | -13.08M |
| September 30, 2017 | -14.81M |
| June 30, 2017 | -37.28M |
| March 31, 2017 | -110.39M |
| December 31, 2016 | -50.12M |
| September 30, 2016 | -53.43M |
| June 30, 2016 | -59.47M |
| March 31, 2016 | -50.86M |
| December 31, 2015 | -83.78M |
| September 30, 2015 | -27.24M |
| June 30, 2015 | -27.86M |
| March 31, 2015 | -27.99M |
| December 31, 2014 | -49.44M |
| September 30, 2014 | -46.51M |
| June 30, 2014 | -58.99M |
| March 31, 2014 | -35.57M |
| December 31, 2013 | -39.44M |
| September 30, 2013 | 174.93M |
| June 30, 2013 | -26.28M |
| March 31, 2013 | -108.28M |
| December 31, 2012 | -59.62M |
| September 30, 2012 | -103.93M |
| June 30, 2012 | -150.55M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-916.14M
Minimum
Mar 2022
90.85M
Maximum
Sep 2020
-112.28M
Average
-59.15M
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies Inc | -100.00M |
| Bruker Corp | -67.60M |
| Azenta Inc | 201.62M |
| Harvard Bioscience Inc | -1.111M |
| Bionano Genomics Inc | 28.63M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 163.61M |
| Cash from Financing (Quarterly) | -95.99M |
| Free Cash Flow | 223.75M |
| Free Cash Flow Per Share (Quarterly) | 3.572 |
| Free Cash Flow to Equity (Quarterly) | 88.91M |
| Free Cash Flow to Firm (Quarterly) | 99.97M |
| Free Cash Flow Yield | 2.25% |